Literature DB >> 7884393

The enigma of neuromelanin in Parkinson's disease substantia nigra.

M B Youdim1, D Ben-Shachar, P Riederer.   

Abstract

The function of neuromelanin accumulation in the nigrostriatal dopamine neurons remains uncertain. Nevertheless, it is recognized that neuromelanin disappearance parallels the loss of dopamine neurons in Parkinson's disease, suggesting its participation in nigral cell death. It has been well known for some years that in systemic tissues melanin is a double-edged sword. On the one hand it can act as an antioxidant, but in the presence of transitional metals (primarily, iron) and drugs it promotes the formation of reactive oxygen free radicals. It is now apparent that synthetic dopamine-melanin and neuromelanin exhibit similar properties in vitro and nigrostriatal dopamine neuron co-culture studies. Thus, the identification of ionic iron in dopamine neurons of Parkinson's disease zona compacta and its association with neuromelanin has conferred a cytotoxic property to neuromelanin. This may explain the reported vulnerability of substantia nigra dopamine neurons in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884393

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  13 in total

Review 1.  The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Authors:  Alessandra Gaeta; Robert C Hider
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

2.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 3.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 4.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

5.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

6.  Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.

Authors:  L Liu; K Wakamatsu; S Ito; P R Williamson
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.

Authors:  Patcharee Kooncumchoo; Sushil Sharma; James Porter; Piyarat Govitrapong; Manuchir Ebadi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

8.  Activation of the alternative complement pathway by fungal melanins.

Authors:  A L Rosas; R S MacGill; J D Nosanchuk; T R Kozel; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

9.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 10.  Metal imaging in neurodegenerative diseases.

Authors:  Megan W Bourassa; Lisa M Miller
Journal:  Metallomics       Date:  2012-07-16       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.